| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/26/2011 | CN101224280B Lick brick for treating animal nutrient metabolism disease |
| 01/26/2011 | CN101066259B Solid dispersion of higher fatty alcohol and its prepn |
| 01/26/2011 | CN101007798B Benzodioxole derivatives and their preparation method and medicinal uses |
| 01/26/2011 | CN101006803B Lipid-lowering milk containing probiotics and its preparation method |
| 01/25/2011 | US7875712 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 01/25/2011 | US7875637 Benzimidazole derivative and use as a II receptor antagonist |
| 01/25/2011 | US7875633 Phenylpyridone derivative |
| 01/25/2011 | US7875625 3-guanidinocarbonyl-2-methyl-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-ylmethyl hydrogen sulfate, inhibitory effect on an Na+/H+ exchanger; |
| 01/25/2011 | US7875616 Use of tyrosine kinase inhibitor to treat diabetes |
| 01/25/2011 | US7875611 Ion channel modulating compounds and uses thereof |
| 01/25/2011 | US7875585 Hematopoietic cell E-selectin / L-selectin ligand glycosylated CD44 polypeptide |
| 01/25/2011 | US7875279 intermediates of the mevalonate-independent pathway for isoprenoid biosynthesis are enriched by deleting or inactivating genes; asthma, morbus Crohn, colitis ulcerosa, multiple sclerosis and chronic bronchitis and immune and auto-immune diseases and allergies and bone diseases and osteoporosis |
| 01/25/2011 | CA2545180C Insulin expressing human pancreatic islet cell line capable of reversibly proliferating and use thereof |
| 01/25/2011 | CA2476983C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of multiple myeloma |
| 01/25/2011 | CA2472776C Process for the manufacture of hmg-coa reductase inhibitors |
| 01/25/2011 | CA2463146C Crystalline sodium salt of telmisartan and the use of same as an angiotensin antagonist |
| 01/25/2011 | CA2458690C Pharmaceutical compositions comprising an ascomycin derivative |
| 01/25/2011 | CA2458528C C2-substituted indan-1-ones and their derivatives, processes for their preparation and their use as medicaments |
| 01/25/2011 | CA2441834C Lipid profile modulation |
| 01/25/2011 | CA2436599C Oral pharmaceutical compositions comprising polyvinylpyrrolidone (pvp) and 5-cnac |
| 01/25/2011 | CA2385322C A substantially cell membrane impermeable compound and use thereof |
| 01/25/2011 | CA2381882C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/25/2011 | CA2369175C Methods for stabilizing liquid nutritional products and products so stabilized |
| 01/25/2011 | CA2344467C Ucp4 |
| 01/25/2011 | CA2163278C Method for production of arachidonic acid |
| 01/20/2011 | WO2011009115A2 Combination therapies for the treatment of obesity |
| 01/20/2011 | WO2011008663A1 Gpr119 agonists |
| 01/20/2011 | WO2011008490A2 Combination therapies for the treatment of obesity |
| 01/20/2011 | WO2011008054A2 Butyric acid salt of n,n-dimethyl imidocarbon imidic diamide, method of preparing same, and pharmaceutical compositions and combinations containing same |
| 01/20/2011 | WO2011007943A1 Method for producing novel gynostemma pentaphyllum extracts having increased amounts of damulin a and damulin b and pharmaceutical composition for treating metabolic diseases using the same |
| 01/20/2011 | WO2011007882A1 Insulin-producing cell inducer, glucose intake enhancer, and therapeutic agent for diabetes or diabetes complications |
| 01/20/2011 | WO2011007864A1 Inhibitor of blood gip level elevation |
| 01/20/2011 | WO2011007863A1 Inhibitor of blood triglyceride level elevation |
| 01/20/2011 | WO2011007839A1 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use |
| 01/20/2011 | WO2011007811A1 Onion extract, and process for production thereof |
| 01/20/2011 | WO2011007792A1 Enzyme composition |
| 01/20/2011 | WO2011007722A1 3-substituted-2-furancarboxylic acid hydrazide derivative and pharmaceutically acceptable salt thereof |
| 01/20/2011 | WO2011007091A1 Derivatives of 5,6-bisaryl-2-pyridine-carboxamide, preparation thereof, and therapeutic use thereof as urotensin-ii receptor antagonists |
| 01/20/2011 | US20110015663 Combination Therapies for the Treatment of Obesity |
| 01/20/2011 | US20110015437 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 01/20/2011 | US20110015370 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 01/20/2011 | US20110015278 Phytol as a cholesterol lowering agent |
| 01/20/2011 | US20110015276 Therapeutical uses of inecalcitol |
| 01/20/2011 | US20110015275 Materials and Methods for Improving Alcohol Metabolism and Alleviating the Effects of Hangovers |
| 01/20/2011 | US20110015270 Novel NIDDM Regimen |
| 01/20/2011 | US20110015240 Thiazole derivative and use thereof as vap-1 inhibitor |
| 01/20/2011 | US20110015235 Novel phenylethynyl derivatives of 8-aza-bicyclo[3.2.1]octane and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/20/2011 | US20110015226 Treatment of Energy Utilization Disease |
| 01/20/2011 | US20110015225 Heterocyclic compound |
| 01/20/2011 | US20110015220 Mixed orl1/mu-agonists for the treatment of pain |
| 01/20/2011 | US20110015215 Crystalline forms of 4-[6-(6-methanesulfonyl-2-methyl-pyridin-3-ylamino)-5-methoxy-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid isopropyl ester |
| 01/20/2011 | US20110015210 Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/20/2011 | US20110015199 GPR119 Agonists |
| 01/20/2011 | US20110015198 Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism |
| 01/20/2011 | US20110015195 Aryl ureas with angiogenisis inhibiting activity |
| 01/20/2011 | US20110015194 Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/20/2011 | US20110015192 Sirtuin modulating compounds |
| 01/20/2011 | US20110015187 Substituted heteroarylamide diazepinopyrimidone derivatives |
| 01/20/2011 | US20110015185 Benzofuran Compounds |
| 01/20/2011 | US20110015184 Vinyl-phenyl derivatives for inflammation and immune-related uses |
| 01/20/2011 | US20110015183 Substituted pyrazole sigma receptor antagonists |
| 01/20/2011 | US20110015181 Alkylaminopyridine derivative |
| 01/20/2011 | US20110015178 Amido-Thiophene Compounds and Their Use |
| 01/20/2011 | US20110015177 Substituted arylamide oxazepinopyrimidone derivatives |
| 01/20/2011 | US20110015176 Substituted heteroarylamide oxazepinopyrimidone derivatives |
| 01/20/2011 | US20110015174 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 01/20/2011 | US20110015164 Method of treating men with metabolic and anthropometric disorders |
| 01/20/2011 | US20110015161 Pharmaceutical containing a horomone combination having a contraceptive effecr and an insulin sensitizer |
| 01/20/2011 | US20110015157 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 01/20/2011 | US20110015142 Method for preparing gynostemma pentaphyllum extract with increasing damulin a and damulin b contents, and pharmaceutical compositions of the same for treating metabolic disease |
| 01/20/2011 | US20110015140 Anti-diabetes composition containing chicoric acid and/or one of the metabolites thereof |
| 01/20/2011 | US20110015130 Polypeptides Selective for alphavbeta3 Integrin Conjugated With a Variant Of Human Serum Albumin (HSA) And Pharmaceutical Uses Thereof |
| 01/20/2011 | US20110015129 New paediatric indications for direct thrombin inhibitors |
| 01/20/2011 | US20110015124 Leptin agonist and methods of use |
| 01/20/2011 | US20110015123 Modulation of GLUT4 Gene Promoter activity BY AHNAK |
| 01/20/2011 | US20110014309 Composition to enhance HDL cholesterol and to decrease intima-media thickening in animals and humans and a method for its preparation |
| 01/20/2011 | US20110014301 Metal compounds, mixed or sulphated, as phosphate binders |
| 01/20/2011 | US20110014299 Solid preparation comprising alogliptin and metformin hydrochloride |
| 01/20/2011 | US20110014294 Stimulation of ocular retrobulbar blood flow using ocular irritants |
| 01/20/2011 | US20110014284 Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof |
| 01/20/2011 | US20110014282 Pharmaceutical composition for poorly soluble drugs |
| 01/20/2011 | US20110014279 Bioactive complex compositions and methods of use thereof |
| 01/20/2011 | US20110014275 Compositions and methods for inhibiting or inducing adipogenesis |
| 01/20/2011 | US20110014251 Microvesicles |
| 01/20/2011 | US20110014247 Methods and compositions for oral administration of proteins |
| 01/20/2011 | US20110014243 Pharmaceutical compositions |
| 01/20/2011 | US20110014226 high throughput protein interaction assay |
| 01/20/2011 | US20110014189 Stable pharmaceutical composition comprising at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituents |
| 01/20/2011 | US20110014177 Methods for Enhancing Physical and Mental Energy |
| 01/20/2011 | US20110014176 Compounds and method for reducing uric acid |
| 01/20/2011 | US20110014164 Efficient induction of pluripotent stem cells using small molecule compounds |
| 01/20/2011 | US20110014163 Differentiation of Human Embryonic Stem Cells |
| 01/20/2011 | DE102009033208A1 Aminopyridinderivate Aminopyridine |
| 01/20/2011 | DE102009027744A1 Prekursor-Verbindungen von Süßrezeptor-Antagonisten zur Prävention oder Behandlung von Krankheiten Precursor compounds of sweet taste receptor antagonists for the prevention or treatment of diseases |
| 01/20/2011 | CA2767887A1 Benzimidazole analogues for the treatment or prevention of flavivirus infections |
| 01/20/2011 | CA2765661A1 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use |
| 01/20/2011 | CA2764906A1 Gpr119 agonists |
| 01/19/2011 | EP2275557A1 Albumin fusion proteins |
| 01/19/2011 | EP2275548A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 01/19/2011 | EP2275433A1 Metastin derivative and use thereof |